Screener
Neuropace, Inc. NPCE Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $541.75M.
The source filing: Neuropace, Inc.’s 10-Q, filed August 11, 2026. Open the filing →
- Filed
- Aug 11, 2026, 4:33 PM EDT
- Fiscal quarter
- Q4 FY2030
- Calendar quarter
- Q4 2030
- Accession
- 0001528287-26-000030
FAQ
- What is Neuropace, Inc.'s market capitalization?
- Neuropace, Inc. (NPCE) reported market capitalization of $541.75M in Q2 2026.
- How has Neuropace, Inc.'s market capitalization changed year-over-year?
- Neuropace, Inc.'s market capitalization increased by 53.5% year-over-year, from $352.91M to $541.75M.
- What is the long-term trend for Neuropace, Inc.'s market capitalization?
- Over 4 years (2021 to 2025), Neuropace, Inc.'s market capitalization has grown at a 20.4% compound annual growth rate (CAGR), from $245.02M to $514.27M.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.
Ask your AI about Neuropace, Inc.'s market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude